Skip to main content
Premium Trial:

Request an Annual Quote

Juan-Sebastian Saldivar, Mark Gold

AltheaDx has appointed Juan-Sebastian Saldivar as chief medical officer and Mark Gold to its board of directors.

Saldivar joins AltheaDx from Sequenom, where he was vice president of clinical services and medical affairs. Previously, he was director of molecular diagnostics and a clinical associate professor in the department of pathology at City of Hope National Medical Center. He also served as director of clinical laboratory services at Perlegen Sciences.

Gold was a distinguished professor in neuroscience and chairman at the University of Florida from 1990 until he retired in June 2014. He has also served as a consultant to banks, private equity firms, global pharmaceutical companies, and venture capital firms on devices, pharmaceuticals and health care delivery. He has served on the board of directors of Viewray and AxoGen.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more